Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.36 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | MGAM | O43451 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | SI | P14410 | 1/20 | 0.33 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.33 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.33 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.33 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11787123 | 0.76 | RECQL (0.41) | ALDH1A1TRPA1KDM4ESMN1; SMN2HSD17B10 | |
| SCHEMBL4388130 | 0.74 | MGAM (0.50) | ALDH1A1TRPA1KDM4EHSD17B10LMNA | |
| SCHEMBL536496 | 0.74 | ALDH1A1 (0.46) | ALDH1A1TRPA1HSD17B10LMNAALOX15 | |
| SCHEMBL891003 | 0.74 | MGAM (0.50) | ALDH1A1TRPA1KDM4EHSD17B10LMNA | |
| SCHEMBL122314 | 0.74 | MGAM (0.50) | ALDH1A1TRPA1KDM4EHSD17B10LMNA | |
| SCHEMBL305091 | 0.74 | SMN1; SMN2 (0.50) | ALDH1A1SMN1; SMN2HSD17B10LMNAALOX15 | |
| SCHEMBL1233485 | 0.72 | MGAM (0.42) | ALDH1A1TRPA1HSD17B10LMNAALOX15 | |
| Ammonia Solution, Strong SCHEMBL2558654 | 0.72 | SMN1; SMN2 (0.48) | ALDH1A1SMN1; SMN2HSD17B10LMNAALOX15 | |
| SCHEMBL22718395 | 0.72 | MGAM (0.48) | ALDH1A1TRPA1KDM4EHSD17B10LMNA | |
| Hydrochloric Acid SCHEMBL3825475 | 0.72 | SMN1; SMN2 (0.48) | ALDH1A1SMN1; SMN2HSD17B10LMNAALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2551039-B1 | COMPLEX OF ORGANIC COMPOUND AND COPPER NANOPARTICLES, COMPLEX OF ORGANIC COMPOUND AND COPPER OXIDE (I) NANOPARTICLES, AND PROCESSES FOR PRODUCTION OF THE COMPLEXES | DAINIPPON INK & CHEMICALS (JP) | 2016-05-11 | — | — | EP | disclosed |
| US-8530559-B2 | Composite of organic compound and copper nanoparticles, composite of organic compound and copper(I) oxide nanoparticles, and methods for producing the composites | DIC CORPORATION (JP) | 2013-09-10 | — | — | US | disclosed |
| US-20130095320-A1 | COMPOSITE OF ORGANIC COMPOUND AND COPPER NANOPARTICLES, COMPOSITE OF ORGANIC COMPOUND AND COPPER(I) OXIDE NANOPARTICLES, AND METHODS FOR PRODUCING THE COMPOSITES | DIC CORPORATION (JP) | 2013-04-18 | — | — | US | disclosed |
| EP-2551039-A1 | COMPLEX OF ORGANIC COMPOUND AND COPPER NANOPARTICLES, COMPLEX OF ORGANIC COMPOUND AND COPPER OXIDE (I) NANOPARTICLES, AND PROCESSES FOR PRODUCTION OF THE COMPLEXES | DIC Corporation (JP) | 2013-01-30 | — | — | EP | disclosed |
| US-20100202950-A1 | Method of Preparing Heterogeneous Catalysts | NEVEROV ALEXEI A | 2010-08-12 | — | — | US | disclosed |
| US-4172207-A | Process for mercaptoalkanedicarboxylic acid esters | MACK GERRY P | 1979-10-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130095320-A1 | COMPOSITE OF ORGANIC COMPOUND AND COPPER NANOPARTICLES, COMPOSITE OF ORGANIC COMPOUND AND COPPER(I) OXIDE NANOPARTICLES, AND METHODS FOR PRODUCING THE COMPOSITES | AOC3, AOC2, CORO1C | ALDH1A1 924/4885TRPA1 619/4885KDM4E 2618/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.